2006
DOI: 10.1016/j.cyto.2007.01.003
|View full text |Cite
|
Sign up to set email alerts
|

Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
158
1
9

Year Published

2009
2009
2021
2021

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 240 publications
(170 citation statements)
references
References 44 publications
2
158
1
9
Order By: Relevance
“…Cytokine production, particularly IL-10, was affected in mucosal cells (49). In a mouse model, exopolysaccharide produced by Lactobacillus kefiranofaciens could modulate immune responses (50). Furthermore, in mice infected with Salmonella enterididis, the survival of mice fed with a nonbacterial fraction of fermented milk was enhanced as compared with the control group (51).…”
Section: Animal Studiesmentioning
confidence: 87%
“…Cytokine production, particularly IL-10, was affected in mucosal cells (49). In a mouse model, exopolysaccharide produced by Lactobacillus kefiranofaciens could modulate immune responses (50). Furthermore, in mice infected with Salmonella enterididis, the survival of mice fed with a nonbacterial fraction of fermented milk was enhanced as compared with the control group (51).…”
Section: Animal Studiesmentioning
confidence: 87%
“…Kefiran also exhibits a potential role in intestinal homeostasis, with an increase in luminal IgA and of both pro-and anti-inflammatory cytokines, such as IFN-c, TNFa, IL-6 and IL-10, observed in the small and large intestine (Vinderola et al, 2006). In concordance with these homeostatic effects, a study by Sengül et al (2006) demonstrated that EPS-producing bacteria were able to significantly attenuate the inflammation of an experimental colitis model, induced via intracolonic administration of acetic acid, in rats.…”
Section: Exopolysaccharidesmentioning
confidence: 99%
“…EPSs have also been suggested to play a major role in bacterial attachment (Watnick & Kolter, 1999) Kefiran, an EPS produced by a number of strains of lactobacilli in the fermented milk drink kefir, has been shown to possess a number of systemic physiological activities; these include wound-healing properties, reduction of blood pressure and cholesterol levels, and the retardation of tumour growth in experimental models (Vinderola et al, 2006). Kefiran also exhibits a potential role in intestinal homeostasis, with an increase in luminal IgA and of both pro-and anti-inflammatory cytokines, such as IFN-c, TNFa, IL-6 and IL-10, observed in the small and large intestine (Vinderola et al, 2006). In concordance with these homeostatic effects, a study by Sengül et al (2006) demonstrated that EPS-producing bacteria were able to significantly attenuate the inflammation of an experimental colitis model, induced via intracolonic administration of acetic acid, in rats.…”
Section: Exopolysaccharidesmentioning
confidence: 99%
See 1 more Smart Citation
“…health promoting beverage and source of organisms (Vinderola et al, 2006;Walsh et al, 2016). Kefir has been associated with various health benefits through examining the mechanisms (Liu et al, 2012).…”
Section: Introductionmentioning
confidence: 99%